{"disease":{"id":"vexas","name":"vexas"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05200715","title":"AutoInflammatory Disease Alliance Registry (AIDA)","phase":"","overall_status":"RECRUITING","enrollment_count":3500,"lead_sponsor_name":"University of Siena","has_results":false},{"nct_id":"NCT06004349","title":"Autoimmune and Autoinflammatory Genetics Study","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"NYU Langone Health","has_results":false},{"nct_id":"NCT07102849","title":"Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1400,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT06377462","title":"Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Technische Universität Dresden","has_results":false},{"nct_id":"NCT07569081","title":"A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":192,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT06657846","title":"HRQoL and Financial Toxicity in Patients With VEXAS Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Gruppo Italiano Malattie EMatologiche dell'Adulto","has_results":false},{"nct_id":"NCT06782373","title":"A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":78,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":false},{"nct_id":"NCT06538181","title":"Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Washington University School of Medicine","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}